Applications for this job are now closed
GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company that combines both individual talent and technical resources to create a platform for the delivery of strong growth in a rapidly changing healthcare market. Our mission is to improve the quality of human life by enabling people to do more, feel better and live longer.
Biopharm Discovery is a research department dedicated to the discovery of novel and effective biopharmaceutical medicines. The department comprises several complementary functions focused on the progression of a portfolio of biopharmaceuticals from initial antibody discovery, expression and characterisation to molecular engineering and biological and physiochemical profiling.
We are currently seeking multiple lab-based graduate scientist roles across all functions of Biopharm Discovery
We would like to hear from enthusiastic, dynamic and self-motivated individuals who have a keen interest in starting a laboratory-based career. We are seeking a diverse pool of candidates with a background/interest in a range of disciplines including: molecular biology, gene editing, cell biology, biochemistry, antibody display technologies, protein engineering, antibody pharmacology, translational biology or other related disciplines.
Why you?
Qualifications & Skills (dependent on role offered)
We are looking for candidates with these required skills to achieve our goals:
- Graduate/post-graduate degree or equivalent experience in protein engineering, pharmacology, analytics, molecular biology or related discipline
- Ability to work as part of a team
- Good analytical and data interpretation skills
- Ability to review and assimilate new information effectively
- Excellent interpersonal and communication skills
Preferred Qualifications & Skills
If you have some of the following characteristics, it would be a plus:
- Previous lab-based experience in the cloning, expression, purification, antibody display, analytics and/or biological assay characterisation of proteins
- Demonstratable understanding of the antibody discovery process
- Scientific knowledge of antibody structure and function
- Interest in fusion proteins, multi-specific antibodies or other formats
- Interest in application of automation to biological processes
Why GSK?
At GSK, we have delivered unprecedented change over the past four years - to improve R&D productivity and performance, transform commercial execution and to strengthen our leadership and reshape our organisation. Now, we’re getting ready to deliver the most significant change to our company in over 20 years. We’re on track to separate and create two ambitious new companies in 2022: A new GSK with a leading portfolio of vaccines, specialty and general medicines, and R&D based on the science of the immune system and genetics; and a new world-leading consumer healthcare company built on brands and innovation and delivering better everyday health.
With new ambition comes new purpose. GSK will unite science, talent, and technology to get ahead of disease together. We’ll be a company where outstanding people thrive, delivering strong, sustainable returns to our shareholders and with the power to improve the health of more than 2.5 billion people over the next 10 years.
All of this depends on our people and our culture. A culture that is ambitious for patients – so we deliver what matters better and faster; where we are all accountable for our impact and supported to succeed; and where we do the right thing. So, if you share our ambition, join us at this exciting moment in our journey to get Ahead Together.
Closing Date for Applications: 1st April 2022
Please take a copy of the Job Description, as this will not be available post closure of the advert.
When applying for this role, please use the ‘cover letter’ of the online application or your CV to describe how you meet the competencies for this role, as outlined in the job requirements above. The information that you have provided in your cover letter and CV will be used to assess your application.
During the course of your application you will be requested to complete voluntary information which will be used in monitoring the effectiveness of our equality and diversity policies. Your information will be treated as confidential and will not be used in any part of the selection process. If you require a reasonable adjustment to the application / selection process to enable you to demonstrate your ability to perform the job requirements, please contact 0808 234 4391. This will help us to understand any modifications we may need to make to support you throughout our selection process.
R&D At GSK, we want to find new medicines and vaccines in ways that are faster, more effective and more predictable.
We start with what matters most, the science. Our approach to R&D focuses on science related to the immune system, the use of human genetics, and advanced technologies. Our pipeline currently comprises of more than 60 vaccines and medicines across four core therapeutic areas including oncology, infectious diseases, immunology / respiratory and HIV. We have pivotal study starts in 2021 for our RSV vaccine in older adults, COVID-19 assets, long-acting anti-IL-5 antagonist, daprodustat, and dostarlimab. In oncology, momentum is building with 15 potential medicines in trials, including nine immuno-oncology and three cell therapies.
We give our scientists the freedom to own the process. Our scientists often use genetic data to help us understand the root cause of disease. We steer the research where the data shows we can do most good. If a project doesn’t pan out, we take what we’ve learned and apply it elsewhere.
Technology can help us find patterns in genetic data better and faster. We’re using machine learning to unlock the potential of complex genetic data with new levels of speed, precision, and scale. And we’re one of the first biopharmaceutical companies to have created an in-house AI lab dedicated to drug development.
Even with the knowledge, tools, and resources within GSK, there’s always a benefit to new perspectives. That's why we're increasingly partnering with and hiring outstanding people from cutting edge fields like tech, data-science and academia. In 2018, GSK formed an exclusive, highly innovative collaboration with 23andMe, the world's leading consumer genetics and research company. Other partners include: the Altius Institute; the UK Biobank, which is generating anonymized genetic sequence data from 500,000 volunteers; and the Open Targets Consortium, the mindset and approach of smaller, more agile startups.
